Nabi Biopharmaceuticals

UEI
DK92BKNVVVB9
CAGE
Not on record
Primary NAICS
Not on record
SAM.gov registration
Expired

Company facts

Entity structure
Other
Corporate family

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Nabi Biopharmaceuticals's 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Phase III study of a nicotine vaccine for smoking cessation Grant · RC2DA028837 National Institutes of Health $10,007,124
A randomized, multicenter trial to evaluate the safety and immunogenicity of staphylococcus aureus toxoids, RAT and… Grant · W81XWH0920151 Department of the Army $471,917
Efficacy of a nicotine vaccine for smoking cessation Grant · R01DA017894 National Institutes of Health $1,421,797
Delivery Order 200960528-00200200108C0000200960528 Contract · 00200200108C0000200960528 CDC Office of Acquisition Services $194,000
Delivery Order 200960530-00200200108C0000200960530 Contract · 00200200108C0000200960530 CDC Office of Acquisition Services -$69,000

Quick answers

What is Nabi Biopharmaceuticals's UEI?

Nabi Biopharmaceuticals's Unique Entity ID (UEI) in SAM.gov is DK92BKNVVVB9.

Is Nabi Biopharmaceuticals registered in SAM.gov?

Nabi Biopharmaceuticals's SAM.gov registration expired on August 15, 2001.

What is Nabi Biopharmaceuticals's most recent federal award?

Nabi Biopharmaceuticals's most recent federal grant award is Phase III study of a nicotine vaccine for smoking cessation (RC2DA028837), from National Institutes of Health, on September 30, 2009.

On GovTribe

See Nabi Biopharmaceuticals's full federal record

  • Federal contract awards
  • IDV awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login